Home Page - San Diego Hematologic Malignancies Symposium 2026

The San Diego Hematologic Malignancies Symposium 2026: Advancing Evidence-Based Care in Leukemia, Lymphoma, and Myeloma is a one-day, CME/CPD-accredited educational program designed to deliver the latest evidence-based advances in the diagnosis, risk stratification, and management of hematologic cancers, including leukemia, lymphoma, and multiple myeloma.

This symposium brings together leading experts in hematology and oncology to present emerging data, guideline updates, and real-world clinical insights across the continuum of care. Through a combination of didactic lectures, case-based discussions, and interactive sessions, participants will explore novel therapeutics such as targeted agents, immunotherapies, CAR T-cell therapy, and bispecific antibodies, as well as strategies to manage treatment-related toxicities and improve patient outcomes.

Aligned with ACCME standards for independence and scientific rigor, this activity is designed to address current practice gaps, reduce variability in care, and support clinicians in delivering personalized, patient-centered treatment for individuals with hematologic malignancies.

Binaytara is a leading global oncology 501(c)(3) nonprofit, dedicated to reducing cancer health disparities around the world. Founded in 2007 by Tara Shah and Dr. Binay Shah, our mission is to improve access to cancer care, enhance continuing medical education (CME), and foster implementation science research in hematology and oncology, thereby reducing the global burden of cancer.

As the largest cancer conference organizer in the US, we impact thousands of doctors and oncology/hematology practitioners who attend our conferences to stay current on cutting-edge treatments for their patients. Binaytara is an accredited CME provider committed to improving patient outcomes through high-quality, independent CME activities for physicians, pharmacists, and nurses.

As a leader in global oncology, we have partnered with local government and health organizations in Nepal to operate the only cancer hospital in Madhesh Province, deliver cervical cancer screenings, provide nurse training, and establish the first bone marrow transplant center in the country. In India, we have partnered with government institutions to establish hospice and palliative care programs in Madhya Pradesh. We are beginning construction in 2024 on a comprehensive 200-bed cancer center in Janakpur, Nepal that will dramatically improve access to cancer care in Nepal and surrounding communities.

We invite companies interested in improving equitable access to cancer care to support our efforts.

Sheraton San Diego Resort